{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:16:32Z","timestamp":1780586192987,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Data in Brief"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.dib.2020.106116","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T13:45:50Z","timestamp":1596289550000},"page":"106116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Data on chloroquine\/hydroxychloroquine content in compounded oral suspension after filtration and centrifugation"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-4152","authenticated-orcid":false,"given":"U.M.","family":"Musazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.G.","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fortini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Maximova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3560-291X","authenticated-orcid":false,"given":"F.","family":"Cilurzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Minghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dib.2020.106116_bib0001","unstructured":"Council of Europe, Resolution CM\/Res(2016)1 on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients. https:\/\/www.edqm.eu\/sites\/default\/files\/resolution_cm_res_2016_1_quality_and_safety_assurance_requirements_for_medicinal_products_prepared_in_pharmacies.pdf [Accessed: 28 July 2020]."},{"key":"10.1016\/j.dib.2020.106116_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2020.105552","article-title":"Data on the stability of darunavir\/cobicistat suspension after tablet manipulation","volume":"30","author":"Zanon","year":"2020","journal-title":"Data Brief"},{"key":"10.1016\/j.dib.2020.106116_bib0003","doi-asserted-by":"crossref","DOI":"10.7326\/M20-4207","article-title":"Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19","author":"Skipper","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.dib.2020.106116_bib0004","unstructured":"FDA. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or [Accessed: 20 July 2020]."},{"key":"10.1016\/j.dib.2020.106116_bib0005","unstructured":"EDQM. Products and extemporaneous preparation of paediatric formulations that may be useful in the treatment of COVID-19. https:\/\/www.edqm.eu\/en\/news\/products-and-extemporaneous-preparation-paediatric-formulations-may-be-useful-treatment-covid [Accessed: 20 July 2020]."},{"key":"10.1016\/j.dib.2020.106116_bib0006","unstructured":"Liquid preparation for oral use (01\/2018:0672). Ph. Eur. 10.0. https:\/\/pheur.edqm.eu\/app\/10-2\/content\/10-2\/0672E.htm?highlight=on&terms=liquid&terms=for%20oral%C2%A0use&terms=for%20oral%20use&terms=for&terms=use&terms=oral&terms=preparation&terms=for%20oral&terms=preparation%20for%20oral%20use&terms=preparation.%20liquid&terms=for%20liquid&terms=liquid%20preparation%20for%20oral%20use [Accessed: 28 July 2020]"},{"key":"10.1016\/j.dib.2020.106116_bib0007","unstructured":"Chloroquine Phosphate Compounded Oral Suspension. USP43-NF38 \u2013 960. https:\/\/online.uspnf.com\/uspnf\/current-document\/1_GUID-865C7780-56AF-4F45-A6D7-0623D98FA7B1_1_en-US?source=emailLink [Accessed: 28 July 2020]"},{"key":"10.1016\/j.dib.2020.106116_bib0008","unstructured":"AIFA Banca Dati Farmaci dell'AIFA. https:\/\/farmaci.agenziafarmaco.gov.it\/bancadatifarmaci\/home [Accessed: 2 June 2020]."},{"key":"10.1016\/j.dib.2020.106116_bib0009","doi-asserted-by":"crossref","first-page":"248\u2010254","DOI":"10.1016\/j.jpba.2017.06.023","article-title":"A comprehensive stability-indicating HPLC method for determination of chloroquine in active pharmaceutical ingredient and tablets: identification of oxidation impurities","volume":"145","author":"Coelho","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.dib.2020.106116_bib0010","unstructured":"Development of compounded preparation monograph for hydroxychloroquine sulphate compounded oral suspension. USP. https:\/\/online.usppf.com\/usppf\/document\/GUID-D2EAAA62-4DB9-4C4C-B672-0EC12846BADC_10101_en-US [Accessed: 2 May 2020]."}],"container-title":["Data in Brief"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352340920310106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352340920310106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:55:19Z","timestamp":1762451719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352340920310106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":10,"alternative-id":["S2352340920310106"],"URL":"https:\/\/doi.org\/10.1016\/j.dib.2020.106116","relation":{},"ISSN":["2352-3409"],"issn-type":[{"value":"2352-3409","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Data on chloroquine\/hydroxychloroquine content in compounded oral suspension after filtration and centrifugation","name":"articletitle","label":"Article Title"},{"value":"Data in Brief","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dib.2020.106116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106116"}}